LUT014

· Lutris Pharma Ltd.

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for LUT014, covering 2022-07-27 to 2023-10-06. Get the full timeline:

Most recent: Clinical Trial Update: LUT014 for the Reduction of Dose-Limiting Acneiform Lesions Associated With EGFRI Treatment of mCRC [Phase 2]